GSK, AZN 1st To Use NVDA's Supercomputer, IOVA To Delay BLA Filing, YMAB Plunges, GLYC On Watch

Today's Daily Dose brings you news about Eidos' merger with BridgeBio, the first pharmaceutical companies that will make use of the most powerful supercomputer, known as "Cambridge-1", the FDA granting Rare Pediatric Disease Designation to GlycoMimetics' sickle cell disease drug candidate, and the delay in filing of Lifileucel BLA by Iovance, among others.

from RTT - Biotech https://ift.tt/3nou3Be
via IFTTT